辛基酚的体内类雌激素活性评价

利用体内大鼠子宫增重试验检测辛基酚（OP）的类雌激素活性，并对其观测终点及影响因素进行了初步研究。结果显示，OP经大鼠体内染毒，可引起大鼠子宫湿重、子宫内皮细胞厚度、子宫腺数量明显增加，具有明显的类雌激素活性。三条染毒途径检测敏感度腹腔染毒＞经皮下染毒＞经灌胃染毒。     

四川妇女血清中多溴联苯醚的浓度水平与组成特征

用气相色谱-质谱的选择离子法测定四川省妇女血清中多溴联苯醚的质量浓度,并对其组成特征及主要来源进行了研究.在被测的11种多溴联苯醚当中,BDE-209是主要成分,质量浓度从0.12～2.38μg.L-1,中值为0.63μg.L-1,占多溴联苯醚总量的质量分数为63.57%～90.34%,其次是BDE-66、-99和-100,其它多溴联苯醚几乎没有检出,表明污染主要来自十溴联苯醚,其次是四溴和五溴联苯醚.实验结果与其它国家的数据相比,表明多溴联苯醚对普通妇女的污染在四川还处于一个较低的水平.     

沉积物中雌激素及壬基酚、辛基酚、双酚A的测定

近些年来雌激素及烷基酚类化合物由于其对水生生物的内分泌干扰作用越来越受到广泛关注.沉积物作为环境中有机污染物的重要储存库,研究目标物在其中的浓度分布对于探明此类物质在环境中的迁移转化具有重要意义.但沉积物中基质组成复杂而雌激素又痕量存在,这增加了前处理的难度.本研究从雌激素及烷基酚类化合物的理化性质入手,采用碱液提取、液液萃取和LC-MS/MS分析测定沉积物样品中的雌激素及壬基酚、辛基酚、双酚A.结果表明,经过优化的方法对7种目标物的回收率介于61.9%～93.7%之间.该方法能有效去除沉积物中那些不溶于强碱和既溶于酸又溶于碱的有机污染物,同时操作简单、成本低,但回收率高、检出限低,可广泛适用于河流沉积物样品及土壤样品的前处理.     

内分泌干扰物在城市污水处理厂中的行为和归趋：综述

内分泌干扰物作为一类新型污染物,由于其在环境水体中微量的浓度即可对野生动物产生内分泌干扰效应,因此引起了人们的广泛关注.本文以两类主要内分泌干扰物(即类固醇雌激素和酚类内分泌干扰物)作为研究对象,综述了它们在城市污水处理厂中的浓度水平以及相应的去除效率,并探讨了不同生物处理工艺、运行操作条件等对去除效率的影响.此外,通...     

崇明典型水生生物中雌激素含量和分布特征

采用超高效液相色谱串联质谱系统(UHPLC-MS2)检测崇明岛9种典型水生生物体中5种典型雌激素的含量,包括雌酮(E1)、雌二醇(E2)、雌三醇(E3)、炔雌醇(EE2)和双酚A(BPA).并探讨其分布特征,进行初步健康风险评价.结果表明,9种典型水生生物中雌激素总量(以dw计)为1.1~7.38 ng·g-1,平均为4.25 ng·g-1.雌激素脂肪含量(以lw计)在5.01~83.41 ng·g-1之间,平均值为40.75 ng·g-1,雌激素脂肪含量水平表现为鱼类>虾类>蟹类.鱼类和蟹类,虾类之间雌激素脂肪含量差异性显著,蟹类和虾类之间不存在显著差异性.从检出率和检出含量看,甾醇类雌激素(E1、E2、E3和EE2)的残留明显低于酚类雌激素(BPA).E1、E2、E3和EE2的检出率小于66.67%,平均干重含量为0.17~0.69ng·g-1,而BPA的检出率高达100%,检出的平均干重含量为2.60 ng·g-1.健康风险评估结果表明,崇明岛水产品中雌激素对健康影响不大.     

Uptake of cadmium into cells in culture∗

Cadmium has been recognized as pollutant of the environment for many years and numerous studies on its toxic effects have been carried out. Little, however, is known about its metabolic behaviour e.g. why the metal is accumulated so extremely rapidly into the organs of men and animals. Since the study of the individual metabolic steps is very difficult in vivo cell cultures may be used to obtain first indications of what happens in the whole animal.

We used CHO cells in monolayer culture to study the conditions under which the uptake of cadmium occurs. From serumfree medium the metal is accumulated rapidly in the cells. The uptake is inhibited very strongly by the presence of serum or albumin. Accumulation occurs against a concentration gradient and is dependent on the incubation temperature. Below 10°C no cadmium uptake is seen. Several substances which are known to affect cell metabolism have been used to influence cadmium accumulation. Neither inhibitors of energy production nor microtubule or microfilament disruptors showed any substantial effect. In contrast SH‐group blocking agents markedly reduced cadmium uptake.

The results show that cadmium uptake does not occur by passive diffusion but by some active mechanism.     

Toxic masking and synergistic modulation of the estrogenic activity of chemical mixtures in a yeast estrogen screen (YES)

Background, aim and scope

Estrogenic and non-estrogenic chemicals typically co-occur in the environment. Interference by non-estrogenic chemicals may confound the assessment of the actual estrogenic activity of complex environmental samples. The aim of the present study was to investigate whether, in which way and how seriously the estrogenic activity of single estrogens and the observed and predicted joint action of estrogenic mixtures is influenced by toxic masking and synergistic modulation caused by non-estrogenic chemical confounders.

Materials and methods

The yeast estrogen screen (YES) was adapted so that toxicity and estrogenicity could be quantified simultaneously in one experimental run. Mercury, two organic solvents (dimethyl sulfoxide (DMSO) and 2,4-dinitroaniline), a surfactant (LAS-12) and the antibiotic cycloheximide were selected as toxic but non-estrogenic test chemicals. The confounding impact of selected concentrations of these toxicants on the estrogenic activity of the hormone 17ß-estradiol was determined by co-incubation experiments. In a second step, the impact of toxic masking and synergistic modulation on the predictability of the joint action of 17ß-estradiol, estrone and estriol mixtures by concentration addition was analysed.

Results

Each of the non-estrogenic chemicals reduced the apparent estrogenicity of both single estrogens and their mixtures if applied at high, toxic concentrations. Besides this common pattern, a highly substance- and concentration-dependent impact of the non-estrogenic toxicants was observable. The activity of 17ß-estradiol was still reduced in the presence of only low or non-toxic concentrations of 2,4-dinitroaniline and cycloheximide, which was not the case for mercury and DMSO. A clear synergistic modulation, i.e. an enhanced estrogenic activity, was induced by the presence of slightly toxic concentrations of LAS-12. The joint estrogenic activity of the mixture of estrogens was affected by toxic masking and synergistic modulation in direct proportion to the single estrogens, which allowed for an adequate adaptation of concentration addition and thus unaffected predictability of the joint estrogenicity in the presence of non-estrogenic confounders.

Discussion

The modified YES proved to be a reliable system for the simultaneous quantification of yeast toxicity and estrogen receptor activation. Experimental results substantiate the available evidence for toxic masking as a relevant phenomenon in estrogenicity assessment of complex environmental samples. Synergistic modulation of estrogenic activity by non-estrogenic confounders might be of lower importance. The concept of concentration addition is discussed as a valuable tool for estrogenicity assessment of complex mixtures, with deviations of the measured joint estrogenicity from predictions indicating the need for refined analyses.

Conclusions

Two major challenges are to be considered simultaneously for a reliable analysis of the estrogenic activity of complex mixtures: the identification of known and suspected estrogenic compounds in the sample as well as the substance- and effect-level-dependent confounding impact of non-estrogenic toxicants.

Recommendations and perspectives

The application of screening assays such as the YES to complex mixtures should be accompanied by measures that safeguard against false negative results which may be caused by non-estrogenic but toxic confounders. Simultaneous assessments of estrogenicity and toxicity are generally advisable.     

城市污水处理厂内分泌干扰物浓度分布和去除规律

采集南方某城市3个污水处理厂进出水及各工艺单元的水样,通过固相萃取-衍生化过程对水样进行预处理,并用气相色谱-质谱联用仪定量检测水样中的17α-雌二醇(17α-E2)、雌酮(E1)、雌二醇(E2)、雌炔醇(EE2)、雌三醇(E3)、辛基酚(OP)、正壬基酚(NP)和双酚A(BPA)等8种内分泌干扰物(EDCs).连续4个季度的分析结果显示,3个污水厂进出水及各工艺单元中均有EDCs检出,EE2和BPA是含量最高的两种EDCs,出水中最高浓度分别达到498.9ng.L-1和2652.5ng.L-1,其他6种EDCs浓度均不超过100ng.L-1;生物处理工艺对EE2、E3、NP、OP和BPA有较高的去除率,平均去除率约为57%～85%,但对于E1、E2和17α-E2的去除率较低且不稳定;一级处理工艺对EDCs仅有低于18%的去除率;紫外辐照消毒工艺对EDCs的去除没有明显效果;EDCs浓度季节差异显著,由于雨水的稀释作用,旱季浓度约为雨季的2.5～7.8倍.本文对于了解我国南方地区污水处理工艺中EDCs类物质的分布和转化特点有一定的参考意义.     

药品和个人护理用品(PPCPs)对环境的污染现状与研究进展

在过去的30多年中，有关有毒污染物的研究主要集中在工业化学物质和农药上。近5年多来，国外已经开始关注药品和个人护理用品（PPCPs）对环境的污染，但在我国还没有引起重视。国外的研究表明，合成麝香物质、显影剂、抗生素、雌激素、消炎止痛药、杀菌消毒剂等与人类生活密切相关的药品和个人护理用品在环境中普遍存在，但是其质量浓度通常非常低，多数情况下在ng/L～μg/L水平。粪便施肥和污水排放是PPCPs进入环境的主要途径。在常见的PPCPs中，抗生素和消炎止痛药在环境中检测出的频率最高，在地表水、地下水、饮用水、污泥、土壤等环境介质中，PPCPs在地表水中检测出的频率最高。目前关于PPCPs的研究主要集中在分析方法以及环境污染水平的调查，有关PPCPs在环境中的迁移转化规律，生态与健康风险以及PPCPs污染控制技术等方面的研究有待加强。